Aurinia Pharmaceuticals, Inc. (AUPH)
14.84
-0.03
(-0.20%)
USD |
NASDAQ |
Jan 16, 16:00
14.49
-0.35
(-2.36%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap: 1.957B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 110.83M |
| Edesa Biotech, Inc. | 9.982M |
| Lexaria Bioscience Corp. | 18.60M |
| Xenon Pharmaceuticals, Inc. | 3.092B |
| ProMIS Neurosciences, Inc. | 17.86M |
Market Cap Related Metrics
| PE Ratio | 26.45 |
| PS Ratio | 7.878 |
| Price to Book Value | 5.349 |
| Price to Free Cash Flow | 17.39 |
| Price | 14.84 |
| Earnings Yield | 3.78% |
| Operating PE Ratio | 21.56 |
| Normalized PE Ratio | 23.12 |